EE528 Comparative Effectiveness Modeling of an Anti-Pd-1 Antibody Drug Intervention for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in the U.S.
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2311
https://www.valueinhealthjournal.com/article/S1098-3015(24)02525-7/fulltext
Title :
EE528 Comparative Effectiveness Modeling of an Anti-Pd-1 Antibody Drug Intervention for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in the U.S.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02525-7&doi=10.1016/j.jval.2024.03.2311
First page :
Section Title :
Open access? :
No
Section Order :
10278